New scan could spare thyroid cancer patients from ineffective radiation

NCT ID NCT00673010

Summary

This study tested a new scanning method to predict how well standard radioactive iodine treatment works for thyroid cancer that has spread. Researchers used a different radioactive tracer (124-I) with PET scans to measure how much radiation would reach each tumor before giving the actual treatment (131-I). The goal was to identify patients who wouldn't benefit from the treatment, sparing them unnecessary radiation, and to customize doses for those who would benefit.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for THYROID CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10065, United States

Conditions

Explore the condition pages connected to this study.